[Readministration of oxaliplatin using a rapid desensitization method after severe anaphylactic reaction].
Arotçarena
R
R
Berthélémy
P
P
Piot
M
M
Pariente
A
A
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced* / Q000145:classification / Q000517:prevention & control*; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage* / Q000009:adverse effects*; D000077150:Oxaliplatin; D012720:Severity of Illness Index; D012811:Sigmoid Neoplasms / Q000188:drug therapy / Q000473:pathology
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin